[go: up one dir, main page]

NO1998002I1 - Etoposide phosphate - Google Patents

Etoposide phosphate

Info

Publication number
NO1998002I1
NO1998002I1 NO1998002C NO1998002C NO1998002I1 NO 1998002 I1 NO1998002 I1 NO 1998002I1 NO 1998002 C NO1998002 C NO 1998002C NO 1998002 C NO1998002 C NO 1998002C NO 1998002 I1 NO1998002 I1 NO 1998002I1
Authority
NO
Norway
Prior art keywords
etoposide phosphate
etoposide
phosphate
Prior art date
Application number
NO1998002C
Other languages
Norwegian (no)
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO1998002I1 publication Critical patent/NO1998002I1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/24Condensed ring systems having three or more rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Mechanical Coupling Of Light Guides (AREA)
  • Cable Accessories (AREA)
NO1998002C 1987-08-04 1998-01-14 Etoposide phosphate NO1998002I1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8149387A 1987-08-04 1987-08-04
US07/199,731 US4904768A (en) 1987-08-04 1988-05-27 Epipodophyllotoxin glucoside 4'-phosphate derivatives

Publications (1)

Publication Number Publication Date
NO1998002I1 true NO1998002I1 (en) 1998-01-14

Family

ID=26765636

Family Applications (4)

Application Number Title Priority Date Filing Date
NO883299A NO170284C (en) 1987-08-04 1988-07-26 ANALOGUE PROCEDURE FOR PREPARATION OF PHARMACOLOGICAL ACTIVE 4'-PH SFATE DERIVATIVES OF 4'-DEMETHYLE PIPODYLLOTOXING LOCOSIDES
NO920277A NO920277D0 (en) 1987-08-04 1992-01-22 CHEMICAL COMPOUND AND PROCEDURE FOR PREPARING THEREOF, AND USING THE COMPOUND
NO920665A NO172440C (en) 1987-08-04 1992-02-20 CHEMICAL CONNECTION
NO1998002C NO1998002I1 (en) 1987-08-04 1998-01-14 Etoposide phosphate

Family Applications Before (3)

Application Number Title Priority Date Filing Date
NO883299A NO170284C (en) 1987-08-04 1988-07-26 ANALOGUE PROCEDURE FOR PREPARATION OF PHARMACOLOGICAL ACTIVE 4'-PH SFATE DERIVATIVES OF 4'-DEMETHYLE PIPODYLLOTOXING LOCOSIDES
NO920277A NO920277D0 (en) 1987-08-04 1992-01-22 CHEMICAL COMPOUND AND PROCEDURE FOR PREPARING THEREOF, AND USING THE COMPOUND
NO920665A NO172440C (en) 1987-08-04 1992-02-20 CHEMICAL CONNECTION

Country Status (34)

Country Link
US (3) US4904768A (en)
JP (1) JPH0699465B2 (en)
KR (1) KR900006230B1 (en)
CN (1) CN1027169C (en)
AT (1) AT398974B (en)
BE (1) BE1002982A4 (en)
CA (1) CA1310637C (en)
CH (1) CH676716A5 (en)
CY (1) CY1625A (en)
CZ (1) CZ286893B6 (en)
DD (2) DD299067A5 (en)
DE (1) DE3826562A1 (en)
DK (2) DK169344B1 (en)
ES (1) ES2010775A6 (en)
FI (1) FI87790C (en)
FR (1) FR2622193B1 (en)
GB (1) GB2207674B (en)
GR (1) GR1000490B (en)
HK (1) HK6392A (en)
HU (3) HU208147B (en)
IE (1) IE61040B1 (en)
IL (1) IL87290A (en)
IT (1) IT1226825B (en)
LU (2) LU87290A1 (en)
MX (1) MX173843B (en)
MY (1) MY104321A (en)
NL (2) NL192683C (en)
NO (4) NO170284C (en)
NZ (1) NZ225615A (en)
PT (1) PT88186B (en)
SE (1) SE502214C2 (en)
SG (1) SG101291G (en)
SK (1) SK541288A3 (en)
YU (3) YU143688A (en)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5191071A (en) * 1987-08-21 1993-03-02 Novo Nordisk A/S Monoesters of glycosides and a process for enzymatic preparation thereof
US4965348A (en) * 1989-05-19 1990-10-23 Bristol-Myers Company Dimeric epipodophyllotoxin glucoside derivatives
US5036055A (en) * 1989-06-07 1991-07-30 Bristol-Myers Company Acylated derivatives of etoposide
US5066645A (en) * 1989-09-01 1991-11-19 Bristol-Myers Company Epipodophyllotoxin altroside derivatives
US6610299B1 (en) 1989-10-19 2003-08-26 Aventis Pharma Deutschland Gmbh Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates
US6475486B1 (en) 1990-10-18 2002-11-05 Aventis Pharma Deutschland Gmbh Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates
US7241595B2 (en) 1989-10-20 2007-07-10 Sanofi-Aventis Pharma Deutschland Gmbh Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates
US5552154A (en) 1989-11-06 1996-09-03 The Stehlin Foundation For Cancer Research Method for treating cancer with water-insoluble s-camptothecin of the closed lactone ring form and derivatives thereof
US5034380A (en) * 1989-11-20 1991-07-23 Bristol-Myers Squibb Company Alkoxymethylidene epipodophyllotoxin glucosides
US5081234A (en) * 1990-04-30 1992-01-14 Bristol-Myers Squibb Co. 4'-demethylepipodophyllotoxin glycosides
US4997931A (en) * 1990-06-11 1991-03-05 Bristol-Myers Squibb Company Epipodophyllotoxin glycosides
TW260671B (en) * 1991-04-29 1995-10-21 Bristol Myers Squibb Co
IT1250692B (en) * 1991-07-23 1995-04-21 PROCEDURE FOR THE PREPARATION OF DEMETYLEPIPODOPHYLOTOXY-BETA-D-GLUCOSIDES.
US5648474A (en) * 1991-10-08 1997-07-15 Bristol-Myers Squibb Crystalline etoposide 4'-phosphate diethanolate
CA2085520C (en) * 1991-12-23 1996-07-16 Uday Shankar Gogate Stable hexahydrate of etoposide 4'-phosphate disodium salt
US6080751A (en) * 1992-01-14 2000-06-27 The Stehlin Foundation For Cancer Research Method for treating pancreatic cancer in humans with water-insoluble S-camptothecin of the closed lactone ring form and derivatives thereof
JP3061476B2 (en) * 1992-04-24 2000-07-10 日本化薬株式会社 Method for producing etoposide phosphate
US5459248A (en) * 1993-11-04 1995-10-17 Bristol-Myers Squibb Company Process of preparing etoposide phosphate and etoposide
FR2725990B1 (en) * 1994-10-21 1997-01-10 Pf Medicament WATER-SOLUBLE DERIVATIVES OF EPIPODOPHYLLOTOXIN, PROCESS FOR THEIR PREPARATION, THEIR USE AS MEDICAMENTS, AND THEIR USE FOR CANCER TREATMENTS
US5942386A (en) * 1995-06-07 1999-08-24 Thomas Jefferson University Anti-fungal agents and methods of identifying and using the same
KR20060025233A (en) * 1996-04-01 2006-03-20 에픽스 메디칼, 인코포레이티드 Imaging Contrast Agents for Bioactivation Diagnostics
US6207673B1 (en) 1997-03-12 2001-03-27 The University Of North Carolina At Chapel Hill Covalent conjugates of topoisomerase I and topoisomerase II inhibitors
WO1999032499A1 (en) * 1997-12-23 1999-07-01 Korea Research Institute Of Chemical Technology 4'-O-DEMETHYL-EPIPODOPHYLLOTOXIN-β-D-GLUCOSIDE ACETAL DERIVATIVES
EP2289549A3 (en) 1999-10-01 2011-06-15 Immunogen, Inc. Immunoconjugates for treating cancer
US6624317B1 (en) 2000-09-25 2003-09-23 The University Of North Carolina At Chapel Hill Taxoid conjugates as antimitotic and antitumor agents
US6506739B1 (en) 2001-05-01 2003-01-14 Telik, Inc. Bis-(N,N'-bis-(2-haloethyl)amino)phosphoramidates as antitumor agents
JP2005511550A (en) * 2001-10-26 2005-04-28 サントル・ナショナル・ドゥ・ラ・ルシェルシュ・シャンティフィク Etoposide and analog derivatives, and pharmaceutical compositions containing the same
NZ574146A (en) 2002-07-15 2010-05-28 Univ Texas Peptides binding to phosphatidylethanolamine and their use in treating viral infections
CN1747747B (en) * 2003-01-06 2012-09-05 安吉奥开米公司 Aprotinin and analogs as carriers across the blood-brain barrier
CN100334090C (en) * 2005-02-02 2007-08-29 南京医科大学 Pyridines podophyllotoxin compounds and their preparation method and use in preparation of pesticides
MX2007010113A (en) * 2005-02-18 2007-12-07 Angiochem Inc Aprotinin polypeptides for transporting a compound across the blood-brain barrier.
US20090016959A1 (en) * 2005-02-18 2009-01-15 Richard Beliveau Delivery of antibodies to the central nervous system
WO2007009229A1 (en) * 2005-07-15 2007-01-25 Angiochem Inc. Use of aprotinin polypeptides as carriers in pharmaceutical conjugates
CN100410266C (en) * 2006-01-11 2008-08-13 重庆华邦制药股份有限公司 Synthetic method of podophyllotoxin phosphate derivatives
JO2660B1 (en) 2006-01-20 2012-06-17 نوفارتيس ايه جي PI-3 Kinase inhibitors and methods of their use
PE20070978A1 (en) * 2006-02-14 2007-11-15 Novartis Ag HETEROCICLIC COMPOUNDS AS INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASES (PI3Ks)
AR060358A1 (en) * 2006-04-06 2008-06-11 Novartis Vaccines & Diagnostic QUINAZOLINS FOR THE INHIBITION OF PDK 1
GB0625283D0 (en) * 2006-12-19 2007-01-24 Cyclacel Ltd Combination
US9365634B2 (en) * 2007-05-29 2016-06-14 Angiochem Inc. Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
US8263644B2 (en) * 2007-09-13 2012-09-11 Bristol-Myers Squibb Company Cytotoxic xanthone compounds
EA034136B1 (en) 2007-11-09 2020-01-09 Перигрин Фармасьютикалз, Инк. Isolated antibody that binds to vegf and uses thereof
UY31545A1 (en) 2007-12-20 2009-08-03 NEW DERIVATIVES OF 2-CARBOXAMIDE CIANOAMINOUREA, ITS SALTS AND PHARMACEUTICALLY ACCEPTABLE PROFARMS, PREPARATION PROCESSES AND APPLICATIONS
TR201905480T4 (en) * 2008-04-18 2019-05-21 Angiochem Inc Pharmaceutical compositions of paclitaxel, paclitaxel analogs or paclitaxel conjugates and their respective preparation and use methods.
BRPI0920209A2 (en) 2008-10-15 2015-12-22 Angiochem Inc conjugates of glp-1 agonists and their uses
CN102245636A (en) 2008-10-15 2011-11-16 安吉奥开米公司 Etoposide and doxorubicin conjugates for drug delivery
WO2010063122A1 (en) * 2008-12-05 2010-06-10 Angiochem Inc. Conjugates of neurotensin or neurotensin analogs and uses thereof
CA2747220A1 (en) 2008-12-17 2010-06-24 Richard Beliveau Membrane type-1 matrix metalloprotein inhibitors and uses thereof
US9173891B2 (en) 2009-04-20 2015-11-03 Angiochem, Inc. Treatment of ovarian cancer using an anticancer agent conjugated to an angiopep-2 analog
US8293753B2 (en) 2009-07-02 2012-10-23 Novartis Ag Substituted 2-carboxamide cycloamino ureas
IN2012DN00248A (en) 2009-07-02 2015-05-01 Angiochem Inc
CA2786294A1 (en) 2010-02-22 2011-08-25 F. Hoffmann-La Roche Ag Pyrido[3,2-d]pyrimidine pi3k delta inhibitor compounds and methods of use
US9586954B2 (en) 2010-06-22 2017-03-07 Demerx, Inc. N-substituted noribogaine prodrugs
AR082418A1 (en) 2010-08-02 2012-12-05 Novartis Ag CRYSTAL FORMS OF 1- (4-METHYL-5- [2- (2,2,2-TRIFLUORO-1,1-DIMETHYL-Ethyl) -PIRIDIN-4-IL] -TIAZOL-2-IL) -AMIDE OF 2 -AMIDA OF THE ACID (S) -PIRROLIDIN-1,2-DICARBOXILICO
PL2670753T3 (en) 2011-01-31 2017-05-31 Novartis Ag Novel heterocyclic derivatives
US9617274B1 (en) 2011-08-26 2017-04-11 Demerx, Inc. Synthetic noribogaine
PT2771342T (en) 2011-10-28 2016-08-17 Novartis Ag Purine derivatives and their use in the treatment of disease
CA2855994A1 (en) * 2011-12-09 2013-06-13 Demerx, Inc. Phosphate esters of noribogaine
US10213432B2 (en) 2012-05-16 2019-02-26 Novartis Ag Dosage regimen for a PI-3 kinase inhibitor
CA2896133A1 (en) 2012-12-20 2014-06-26 Demerx, Inc. Substituted noribogaine
MX378409B (en) 2013-12-06 2025-03-10 Novartis Ag DOSAGE REGIMEN FOR AN ALPHA-ISOMORPHIC SELECTIVE PHOSPHATIDYLINOSITOL 3-KINASE INHIBITOR.
ES2826827T3 (en) 2015-06-15 2021-05-19 Angiochem Inc Methods for the treatment of leptomeningeal carcinomatosis
JP2018532750A (en) 2015-11-02 2018-11-08 ノバルティス アーゲー Dosage regimen of phosphatidylinositol 3-kinase inhibitor
WO2018060833A1 (en) 2016-09-27 2018-04-05 Novartis Ag Dosage regimen for alpha-isoform selective phosphatidylinositol 3-kinase inhibitor alpelisib
KR102378151B1 (en) 2020-05-11 2022-03-24 주식회사 제이앤씨사이언스 New derivatives of β-apopicropodophyllin

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1171314A (en) * 1955-05-13 1959-01-23 Sandoz Ag Condensation products of glucosides with carbonyl compounds and their preparation
NL6613143A (en) * 1965-09-21 1967-03-22
CH464957A (en) * 1965-12-14 1968-11-15 Sandoz Ag Process for the preparation of a new glucoside
CH481913A (en) * 1966-12-13 1969-11-30 Sandoz Ag Process for the production of new glucosides
CH514578A (en) * 1968-02-27 1971-10-31 Sandoz Ag Process for the production of glucosides
CH543502A (en) * 1970-11-20 1973-10-31 Sandoz Ag 4,6-O-Cyclic acetals - of 4'-demethyl-epipodophyllotoxin-beta-D-gluco-pyranoside, with antitumour activity
GB1395820A (en) * 1971-06-05 1975-05-29 Villax I Preparation of 21-inorganic esters of corticosteroids and salts thereof
CH589668A5 (en) * 1973-06-07 1977-07-15 Sandoz Ag Cytostatic (4')-demethyl substd. epipodophyllotoxin - prepd. from the corresp. glucopyranoside with (3)-thiophene-carboxaldehyde
FR2397425A1 (en) * 1977-07-11 1979-02-09 Rhone Poulenc Ind NEW DAUNORUBICIN DERIVATIVES, THEIR PREPARATION AND THE COMPOSITIONS CONTAINING THEM
EP0111058B1 (en) * 1982-11-26 1987-11-04 Nippon Kayaku Kabushiki Kaisha Process for producing 4'-demethyl-epipodophyllotoxin-beta-d-ethylidene-glucoside and acyl-derivative thereof
US4567253A (en) * 1984-02-03 1986-01-28 Tony Durst 2-Substituted derivatives of podophyllotoxin and etoposide
JPS60208910A (en) * 1984-03-31 1985-10-21 Green Cross Corp:The Preparation of composite of hardly water-soluble drug and phospholipid
JPS60246393A (en) * 1984-05-22 1985-12-06 Nippon Kayaku Co Ltd Novel preparation of etoposide
US4739046A (en) * 1985-08-19 1988-04-19 Luzio Nicholas R Di Soluble phosphorylated glucan
IL77334A (en) * 1985-12-16 1991-04-15 Univ Bar Ilan Synthesis of 9-epipodophyllotoxin glucoside derivatives and some novel intermediates therefor
US4916217A (en) * 1987-01-08 1990-04-10 Bristol-Myers Company Phosphorus containing derivatives of epipodophyllotoxin
JPS63192793A (en) * 1987-02-06 1988-08-10 Nippon Kayaku Co Ltd Novel ester of 4'-demethyl-epipodophyllotoxin derivative
US4874851A (en) * 1987-07-01 1989-10-17 Bristol-Meyers Company 3',4'-dinitrogen substituted epipodophyllotoxin glucoside derivatives

Also Published As

Publication number Publication date
HU211960A9 (en) 1996-01-29
IE882378L (en) 1989-02-04
FR2622193A1 (en) 1989-04-28
NL192683B (en) 1997-08-01
YU10390A (en) 1990-06-30
FR2622193B1 (en) 1993-12-17
HUT47303A (en) 1989-02-28
NL970042I2 (en) 2005-06-01
KR900006230B1 (en) 1990-08-27
JPH01100188A (en) 1989-04-18
GR1000490B (en) 1992-07-30
CZ286893B6 (en) 2000-07-12
CA1310637C (en) 1992-11-24
FI883596A7 (en) 1989-02-05
DK434088D0 (en) 1988-08-03
ES2010775A6 (en) 1989-12-01
SE8802815L (en) 1989-02-05
DK169344B1 (en) 1994-10-10
NL192683C (en) 1997-12-02
CN1061225A (en) 1992-05-20
USRE35524E (en) 1997-06-03
GB2207674A (en) 1989-02-08
HU202547B (en) 1991-03-28
SG101291G (en) 1992-01-17
IT8821535A0 (en) 1988-07-28
GR880100512A (en) 1989-05-25
NO920277L (en) 1989-02-24
FI87790B (en) 1992-11-13
IE61040B1 (en) 1994-09-07
CH676716A5 (en) 1991-02-28
AT398974B (en) 1995-02-27
AU610619B2 (en) 1991-05-23
YU143688A (en) 1990-04-30
NO172440C (en) 1993-07-21
NO920665L (en) 1989-02-24
NO172440B (en) 1993-04-13
LU90138I2 (en) 1997-11-26
MX9202851A (en) 1992-06-30
LU87290A1 (en) 1990-02-07
MY104321A (en) 1994-03-31
NO170284B (en) 1992-06-22
US4904768A (en) 1990-02-27
HU208147B (en) 1993-08-30
IT1226825B (en) 1991-02-19
DE3826562C2 (en) 1993-04-08
GB2207674B (en) 1991-09-11
FI883596A0 (en) 1988-08-01
NO920665D0 (en) 1992-02-20
CY1625A (en) 1992-07-10
SK279325B6 (en) 1998-10-07
NL8801934A (en) 1989-03-01
SE502214C2 (en) 1995-09-18
KR890003790A (en) 1989-04-18
PT88186A (en) 1989-06-30
IL87290A (en) 1993-01-31
FI87790C (en) 1993-02-25
NO883299D0 (en) 1988-07-26
SE8802815D0 (en) 1988-08-03
NO883299L (en) 1989-02-24
DD299067A5 (en) 1992-03-26
CN1027169C (en) 1994-12-28
IL87290A0 (en) 1989-01-31
NO170284C (en) 1992-09-30
ATA195588A (en) 1994-07-15
NZ225615A (en) 1991-06-25
JPH0699465B2 (en) 1994-12-07
NO920277D0 (en) 1992-01-22
BE1002982A4 (en) 1991-10-15
PT88186B (en) 1995-07-03
US5041424A (en) 1991-08-20
HK6392A (en) 1992-01-17
SK541288A3 (en) 1998-10-07
HU905862D0 (en) 1991-03-28
DK434088A (en) 1989-02-05
DK11992A (en) 1992-01-31
CZ541288A3 (en) 1999-12-15
NL970042I1 (en) 1998-03-02
AU2030688A (en) 1989-06-08
GB8818462D0 (en) 1988-09-07
DE3826562A1 (en) 1989-02-16
DK11992D0 (en) 1992-01-31
MX173843B (en) 1994-03-30
DD274423A5 (en) 1989-12-20
YU10490A (en) 1990-06-30

Similar Documents

Publication Publication Date Title
NO1998002I1 (en) Etoposide phosphate
DE3890290T1 (en) LEAVING
KR890700364A (en) Evaporator
ATA30988A (en) ALPINSKI
FI86538C (en) Foerfarande Foer framstaellning av klordioxid
ATA174488A (en) ALPINSKI
ATA174288A (en) ALPINSKI
ATA224788A (en) CALCITON INSUPPOSITORIES
FI88774B (en) FOERFARANDE FOER OXIDERING AV EN KATALYSATOR-BAERARYTA
FI88716C (en) Foerfarande Foer framstaellning av pharmacologiskt vaerdefullt pyrrolidinderivat
ES2023963B3 (en) BURNTING PROCEDURE
AT389045B (en) PARAOCCLUSAL LOEFFEL
ATA48687A (en) GUELLEFASS
KR890700720A (en) block
ATA294988A (en) HAECKSLER
BR8802503A (en) ABSORPTION-DIFFUSION REFRIGERATOR
FI88622B (en) FOERFARANDE FOER TERMISK REDUKTION AV AGGLOMERERADE METALLURGISKA MATNINGSMATERIAL
FI88924B (en) FOERFARANDE FOER FRAMSTAELLNING AV NYTT DIOSMINDERIVAT
ATA162787A (en) HOERGERAET
IT1221674B (en) SELF-CENTERING WEAPER
FI930239A0 (en) FOERFARANDE FOER FRAMSTAELLNING AV TUNNSKALIGA POROESA PVC-HARTSPARTIKLAR
FI925208A0 (en) FOERFARANDE FOER FRAMSTAELLNING AV TERAPEUTISKT AKTIVA HETEROCYKLISKT SUBSTITUERADE KINOLINKARBOXYLSYROR
FI925209A7 (en) FOERFARANDE FOER FRAMSTAELLNING AV TERAPEUTISKT AKTIVA HETEROCYKLISKT SUBSTITUERADE FOERENINGAR
ES1006159Y (en) JEWELERY-JEWELRY PENDANT-BROOCH
BR8600478A (en) TWO-HEADED PHOSPHORUS